Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Stryker Corporation (SYK)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

Stryker reports third quarter 2025 operating results

Market reaction Comment Full text

Bionano Genomics Inc (BNGO)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

Market reaction Comment Full text

Veeva Systems Inc (VEEV)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025

Market reaction Comment Full text

iRhythm Technologies Inc (IRTC)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Market reaction Comment Full text

Relay Therapeutics (RLAY)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

Market reaction Comment Full text

Sera Prognostics Inc (SERA)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025

Market reaction Comment Full text

INmune Bio Inc. (INMB)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

Market reaction Comment Full text

Ginkgo Bioworks Holdings Inc. (DNA)

  • Business News
  • Oct. 30, 2025, 20:05 UTC
  • 1
  • 0 comments

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Market reaction Comment Full text

Spok Holdings Inc (SPOK)

  • SEC News
  • Oct. 30, 2025, 20:04 UTC
  • 1
  • 1 comments

(99% Neutral) SPOK HOLDINGS, INC (SPOK) Files Form 8-K

Comment Full text

Gilead Sciences Inc (GILD)

  • SEC News
  • Oct. 30, 2025, 20:04 UTC
  • 1
  • 1 comments

(30% Negative) GILEAD SCIENCES, INC. (GILD) Reports Q4 2025 Financial Results

Comment Full text

Spok Holdings Inc (SPOK)

  • SEC News
  • Oct. 30, 2025, 20:03 UTC
  • 1
  • 0 comments

New Form 10-Q - Spok Holdings, Inc Filed: 2025-10-30 AccNo: 0001289945-25-000057 Size: 5 MB

Comment Full text

Pro-Dex Inc (PDEX)

  • SEC News
  • Oct. 30, 2025, 20:02 UTC
  • 1
  • 0 comments

New Form 10-Q - PRO DEX INC Filed: 2025-10-30 AccNo: 0001079973-25-001655 Size: 3 MB

Comment Full text

ReShape Lifesciences Inc. (RSLS)

  • SEC News
  • Oct. 30, 2025, 20:02 UTC
  • 1
  • 1 comments

(99% Neutral) VYOME HOLDINGS, INC. (RSLS) Announces Regulatory Update

Comment Full text

DexCom Inc (DXCM)

  • SEC News
  • Oct. 30, 2025, 20:02 UTC
  • 1
  • 1 comments

(30% Negative) DEXCOM, INC. (DXCM) Reports Q4 2025 Financial Results

Comment Full text

Gilead Sciences Inc (GILD)

  • Business News
  • Oct. 30, 2025, 20:02 UTC
  • 1
  • 0 comments

Gilead Sciences Announces Third Quarter 2025 Financial Results

Market reaction Comment Full text
  • Previous
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next

Search

News categories

  • Technical Exchange News(10320)
  • Event(1441)
  • SEC News(175080)
  • FDA Approval(9642)
  • Company Report(721)
  • Business News(117499)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin